BiotechTube
Biojo Sciences

Biojo Sciences

San Diego, United States· Est.
biojosciences.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Biojo Sciences, founded in 2019 and based in San Diego, operates as a strategic partner and portfolio builder for innovative biotech companies. It leverages deep industry expertise in business, regulatory, scientific, and financial domains to acquire rights to promising therapies and accelerate their clinical development through tailored support, capital, and partnerships. The company focuses on building a diversified portfolio across high-need therapeutic areas like oncology, CNS, and cell & gene therapy, aiming to de-risk development and deliver long-term returns while getting treatments to patients faster.

OncologyRare DiseasesCNSCell & Gene Therapy

Technology Platform

Integrated operational and financial model for evaluating, acquiring, and accelerating external biotech innovations via strategic partnerships, capital deployment, and tailored development support.

Opportunities

The growing translational gap in complex, high-value areas like gene therapy and AI-driven drug discovery creates demand for specialized partners who provide both capital and development expertise.
Biojo's diversified portfolio approach allows it to capture value from multiple high-growth therapeutic markets while mitigating single-asset risk.

Risk Factors

Success is tied to high-risk biotech assets, exposing the company to clinical failure risk.
The capital-intensive model is vulnerable to downturns in the financing environment.
The company faces intense competition for promising assets from larger, more established players.

Competitive Landscape

Biojo competes with other biotech accelerators, venture capital firms with operational arms, and the business development teams of large pharmaceutical companies. Its differentiation hinges on a highly tailored, hands-on partnership model and deep therapeutic area expertise in cutting-edge modalities.

More companies in Cell & Gene Therapy →More companies in United States →